LAG-3 drugs from arch-rivals Bristol-Myers Squibb and Merck & Co look set to become talking points at this year's ASCO conference after trial results showed their potential as next-generation cancer ...
combo paper is published in AAAI 2020 (demo track). If you use combo in a scientific publication, we would appreciate citations to the following paper: @inproceedings{zhao2020combo, title={Combining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback